Birla Cotsyn (India) Board Meeting Outcome

Birla Cotsyn (India) Q2 FY27 Results: Turns Profitable, Net Profit ₹4.5 Cr

Birla Cotsyn posted a Q2 FY27 profit of ₹448.64 lakh against a prior-year loss. The board also re-appointed Jain Ronak & Co. as internal auditor.

Key figure

Net profit ₹4.5 Cr

Birla Cotsyn (India) Board Meeting Date

Birla Cotsyn scheduled a board meeting for 12 November 2026 to approve unaudited results for the quarter and half year ended September 2026. Trading window closes from 1 October 2026.

Birla Cotsyn (India) Other Announcement

Birla Cotsyn (India) Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter holding is 94.58% while public holding is 5.42%, below the 25% minimum public shareholding requirement.

Birla Cotsyn (India) Other Announcement

Birla Cotsyn (India) Ltd submitted its quarterly shareholding pattern as per Regulation 31. The notes provide historical context regarding past capital restructuring and CIRP proceedings.

Birla Cotsyn (India) Annual General Meeting

Birla Cotsyn (India) Ltd held its 84th Annual General Meeting on September 21, 2026, where shareholders transacted on various ordinary and special business items.

Birla Cotsyn (India) Other Announcement

Birla Cotsyn (India) Limited has announced the closure of its register of members from September 14, 2026, to September 20, 2026. This is for the 84th Annual General Meeting.

Parmeshwari Silk Mills Board Meeting Outcome

Parmeshwari Silk Mills' board noted routine compliance items like trading window closure and shareholding pattern. It also approved related-party transaction disclosures for the half year.

Nurture Well Industries Board Meeting Outcome

Nurture Well Industries appointed M/s Goyal Mittal & Associates as Internal Auditor for a 12-month term, effective November 12, 2026. The appointment was approved at a board meeting held the same day.

Execution

12 months

Jumbo Bag Board Meeting Outcome

Jumbo Bag's board approved unaudited results for the quarter and half-year ended 30 September 2026, already filed separately. It also recommended M/s BH & Associates as internal auditors for FY 2026-27.

Execution

FY 2026-27

Ennature Bio Pharma Board Meeting Outcome

Ennature Bio Pharma's board approved adoption of new Articles of Association to align with SCRA Rules 1957 and group governance. The change is subject to shareholder approval.

Shri Keshav Cements & Infra Board Meeting Outcome

Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.

Balmer Lawrie Investments Board Meeting Outcome

Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.

Execution

FY 2026-27